Sanofi India Ltd (SANOFI)
₹3,204.10
Mkt cap
₹7,379 Cr
P/E ratio
20.20
P/B
8.93
Div yield
2.34%
ROE
43.00%
ROCE
57.50%
EPS (TTM)
₹158.62
Book value
₹359
52W range
2,758–4,898
Sector
Healthcare
Price history
Previous close
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines. [1]
NSE SANOFIBSE 500674
Health check
Mixed
ValuationCheap
ProfitabilityStrong
GrowthLow
TechnicalsBearish
52-week range
−34.58% from high₹3,204
₹2,758+16.17% from low₹4,898
Current
₹3,204.10
Prev close
₹3,189.50
Day
+0.46%
Price performance
1D
+0.02%
1W
+15.05%
1M
+3.84%
3M
−5.24%
6M
−7.13%
1Y
−32.31%
YTD
−22.64%
Financials
Revenue, profit & margin
P/E ratio
20.2×
SANOFI is 41% below the sector median of 34.4×
SANOFI20.2×
Sector median34.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 491 | 469 | 511 | 464 | 524 | 515 | 536 | 406 | 475 | 420 | 472 | 438 | 492 | |
| Expenses | 377 | 370 | 374 | 348 | 404 | 397 | 364 | 311 | 341 | 330 | 330 | 322 | 330 | |
| Operating Profit | 114 | 100 | 137 | 116 | 120 | 118 | 172 | 95 | 134 | 90 | 143 | 115 | 161 | |
| OPM % | 23% | 21% | 27% | 25% | 23% | 23% | 32% | 23% | 28% | 22% | 30% | 26% | 33% | |
| Other Income | 82 | 77 | 41 | 21 | 2 | 14 | 3 | 9 | -22 | 3 | 4 | 6 | 6 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | |
| Profit before tax | 186 | 167 | 169 | 127 | 113 | 122 | 165 | 94 | 102 | 83 | 138 | 112 | 158 | |
| Tax % | 18% | 18% | 19% | 19% | 27% | 25% | 28% | 26% | 26% | 26% | 26% | 26% | 26% | |
| Net Profit | 152 | 138 | 137 | 103 | 82 | 91 | 120 | 70 | 76 | 62 | 103 | 84 | 117 | |
| EPS in Rs | 66.17 | 59.87 | 59.39 | 44.96 | 35.74 | 39.70 | 51.96 | 30.22 | 33.04 | 26.83 | 44.61 | 36.30 | 50.74 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Interim Dividend - Rs 75 Per Share | 75.00 | 5 Nov '26 | 5 Nov '26 |
Shareholding
as of Sep 202660.40%Promoter
Promoters60.40%
FIIs5.73%0.04
DIIs19.40%0.47
Public14.46%0.41
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,777.70 | 34.66 | 4,26,530 | 0.90% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹9,780.00 | 87.14 | 2,59,628 | 0.31% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,613.40 | 80.83 | 1,75,479 | 0.82% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,405.50 | 97.00 | 1,29,972 | 0.08% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,245.50 | 25.52 | 1,24,239 | 0.08% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Dr Reddy's Labs | ₹1,352.00 | 40.30 | 1,12,849 | 0.59% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,378.90 | 35.87 | 1,11,397 | 0.94% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Sanofi India | ₹3,204.10 | 20.24 | 7,379 | 2.34% | 117 | +22.88% | 492 | +3.43% | 57.51% |
| Median: 158 Co. | ₹426.38 | 34.39 | 1,921 | 0.08% | 14 | +22.08% | 175 | +18.92% | 15.12% |
Filings
Annual reports15
Concall transcripts19
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 OctCommunication Of Tax Deduction At Source On Interim Dividend For The Financial Year 2026 29 Oct - Sanofi India declared Rs 75 interim dividend for FY2026; record date 5 November 2026.Announcement under Regulation 30 (LODR)-Dividend Updates 29 Oct - Sanofi India reported Q3 FY2026 results and declared ₹75 interim dividend; record date is 5 November 2026.Record Date For Interim Dividend For The Financial Year 2026 29 OctAnnouncement under Regulation 30 (LODR)-Press Release / Media Release 29 Oct - Q3 FY26 results approved; interim dividend ₹75/share declared, record date 5 Nov 2026.